Ireland And Philadelphia

Shire Receives New Paragraph IV Notice Letter From Watson for ADDERALL XR(R)

Older News

DUBLIN, Ireland and PHILADELPHIA, February 24, 2011 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its subsidiaries Shire LLC and Shire Development Inc.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy